Form D · Biotechnology
Xylogenics, Inc.
Indianapolis, IN · CIK 0001489404
Offering snapshot reported Dec 20, 2010 · SEC filing
- Reported sold
- $300K Offering amount: $350K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jul 27, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 20, 2010 | Initial | $300,000 | No comparison | 9 | SEC filing |
| May 13, 2010 | Initial | $225,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-152162
Source: Form D, filed Dec 20, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Butch Mercer | Executive |
| Mike Neibler | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
351 West 10 Th Street Suite 326
Indianapolis, IN, 46202
Indianapolis, IN, 46202